WithdrawnNCT04311281
FDDNP Protocol for Visualizing Brain Proteinopathies to Assist in the Diagnosis of Persons With Suspected CTE and AD
Studying Dementia pugilistica
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of California, Los Angeles
- Principal Investigator
- Helen Lavretsky, MDUniversity of California, Los Angeles, Semel Institute
- Intervention
- [F-18]FDDNP-PET(biological)
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2021 – 2021
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04311281 on ClinicalTrials.govOther trials for Dementia pugilistica
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07521384Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative TherapyHealing Hope International
- RECRUITINGPHASE3NCT06254469Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's DiseaseCereMark Pharma, LLC
- ENROLLING BY INVITATIONNCT06860828The DIAGNOSE CTE Research Project-IIBoston University
- RECRUITINGNCT07302503Pilot Study Evaluating brainQuant's Ability to Detect Alterations in White Matter in Diffusion MRI, Indicative of Post-traumatic LesionsUniversity Hospital, Strasbourg, France
- RECRUITINGNCT04124029Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)VA Office of Research and Development
- RECRUITINGNCT03218332Post-Concussion Syndrome in Professional Athletes: A Multidisciplinary StudyUniversity Health Network, Toronto